2-230168917-A-ATTAATT

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The NM_080424.4(SP110):​c.*206_*207insAATTAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.54 ( 21210 hom., cov: 0)
Exomes 𝑓: 0.36 ( 4455 hom. )

Consequence

SP110
NM_080424.4 3_prime_UTR

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.76

Publications

1 publications found
Variant links:
Genes affected
SP110 (HGNC:5401): (SP110 nuclear body protein) The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. This gene is a member of the SP100/SP140 family of nuclear body proteins and encodes a leukocyte-specific nuclear body component. The protein can function as an activator of gene transcription and may serve as a nuclear hormone receptor coactivator. In addition, it has been suggested that the protein may play a role in ribosome biogenesis and in the induction of myeloid cell differentiation. Alternative splicing has been observed for this gene and three transcript variants, encoding distinct isoforms, have been identified. [provided by RefSeq, Jul 2008]
SP110 Gene-Disease associations (from GenCC):
  • hepatic veno-occlusive disease-immunodeficiency syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 2-230168917-A-ATTAATT is Benign according to our data. Variant chr2-230168917-A-ATTAATT is described in ClinVar as [Benign]. Clinvar id is 369333.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.586 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SP110NM_080424.4 linkc.*206_*207insAATTAA 3_prime_UTR_variant Exon 19 of 19 ENST00000258381.11 NP_536349.3 Q9HB58-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SP110ENST00000258381.11 linkc.*206_*207insAATTAA 3_prime_UTR_variant Exon 19 of 19 2 NM_080424.4 ENSP00000258381.6 Q9HB58-6

Frequencies

GnomAD3 genomes
AF:
0.536
AC:
79256
AN:
147956
Hom.:
21215
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.444
Gnomad AMI
AF:
0.755
Gnomad AMR
AF:
0.515
Gnomad ASJ
AF:
0.608
Gnomad EAS
AF:
0.432
Gnomad SAS
AF:
0.554
Gnomad FIN
AF:
0.564
Gnomad MID
AF:
0.568
Gnomad NFE
AF:
0.591
Gnomad OTH
AF:
0.549
GnomAD4 exome
AF:
0.358
AC:
96407
AN:
269396
Hom.:
4455
Cov.:
0
AF XY:
0.358
AC XY:
51407
AN XY:
143536
show subpopulations
African (AFR)
AF:
0.283
AC:
2401
AN:
8488
American (AMR)
AF:
0.316
AC:
3933
AN:
12446
Ashkenazi Jewish (ASJ)
AF:
0.379
AC:
3075
AN:
8118
East Asian (EAS)
AF:
0.265
AC:
5283
AN:
19924
South Asian (SAS)
AF:
0.344
AC:
11544
AN:
33558
European-Finnish (FIN)
AF:
0.363
AC:
5262
AN:
14506
Middle Eastern (MID)
AF:
0.364
AC:
405
AN:
1112
European-Non Finnish (NFE)
AF:
0.378
AC:
58936
AN:
156054
Other (OTH)
AF:
0.367
AC:
5568
AN:
15190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
2704
5407
8111
10814
13518
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
400
800
1200
1600
2000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.536
AC:
79282
AN:
148030
Hom.:
21210
Cov.:
0
AF XY:
0.532
AC XY:
38278
AN XY:
71974
show subpopulations
African (AFR)
AF:
0.444
AC:
17884
AN:
40294
American (AMR)
AF:
0.515
AC:
7654
AN:
14872
Ashkenazi Jewish (ASJ)
AF:
0.608
AC:
2089
AN:
3436
East Asian (EAS)
AF:
0.433
AC:
2188
AN:
5056
South Asian (SAS)
AF:
0.554
AC:
2607
AN:
4708
European-Finnish (FIN)
AF:
0.564
AC:
5328
AN:
9444
Middle Eastern (MID)
AF:
0.574
AC:
162
AN:
282
European-Non Finnish (NFE)
AF:
0.591
AC:
39560
AN:
66990
Other (OTH)
AF:
0.552
AC:
1132
AN:
2050
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
1700
3400
5099
6799
8499
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
696
1392
2088
2784
3480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.374
Hom.:
612

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hepatic veno-occlusive disease-immunodeficiency syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-1.8

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5839361; hg19: chr2-231033633; API